156 related articles for article (PubMed ID: 8973032)
1. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan.
Nishioka K; Katayama I; Kondo H; Shinkai H; Ueki H; Tamaki K; Takehara K; Tajima S; Maeda M; Hayashi S; Kodama H; Miyachi Y; Mizutani H; Fujisaku A; Sasaki T; Shimizu M; Kaburagi J
J Dermatol; 1996 Oct; 23(10):677-82. PubMed ID: 8973032
[TBL] [Abstract][Full Text] [Related]
2. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
3. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
Scalapino K; Arkachaisri T; Lucas M; Fertig N; Helfrich DJ; Londino AV; Steen VD; Medsger TA
J Rheumatol; 2006 May; 33(5):1004-13. PubMed ID: 16583463
[TBL] [Abstract][Full Text] [Related]
4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
5. [Scleroderma--systemic sclerosis. Serology, lung function and survival].
Ullman S; Halberg P; Wiik A; Jacobsen S
Ugeskr Laeger; 1999 May; 161(21):3084-90. PubMed ID: 10377851
[TBL] [Abstract][Full Text] [Related]
6. Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.
Sampaio-Barros PD; Bortoluzzo AB; Marangoni RG; Rocha LF; Del Rio AP; Samara AM; Yoshinari NH; Marques-Neto JF
J Rheumatol; 2012 Oct; 39(10):1971-8. PubMed ID: 22896025
[TBL] [Abstract][Full Text] [Related]
7. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
8. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
Czirják L; Kumánovics G; Varjú C; Nagy Z; Pákozdi A; Szekanecz Z; Szucs G
Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
[TBL] [Abstract][Full Text] [Related]
9. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous and serologic subsets of systemic sclerosis.
Ferri C; Bernini L; Cecchetti R; Latorraca A; Marotta G; Pasero G; Neri R; Bombardieri S
J Rheumatol; 1991 Dec; 18(12):1826-32. PubMed ID: 1795320
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases.
Shalev T; Haviv Y; Segal E; Ehrenfeld M; Pauzner R; Levy Y; Langevitz P; Shoenfeld Y
Clin Exp Rheumatol; 2006; 24(4):380-6. PubMed ID: 16956427
[TBL] [Abstract][Full Text] [Related]
12. [Causes of death of patients with systemic sclerosis].
Chwieśko S; Sierakowski S; Kowal-Bielecka O
Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.
Kuwana M; Kaburaki J; Okano Y; Tojo T; Homma M
Arthritis Rheum; 1994 Jan; 37(1):75-83. PubMed ID: 8129766
[TBL] [Abstract][Full Text] [Related]
14. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein].
Behr J; König G; Meurer M; Krieg T
Pneumologie; 1990 Jun; 44(6):822-5. PubMed ID: 2381889
[TBL] [Abstract][Full Text] [Related]
16. [Systemic sclerosis (SSc)].
Ishikawa O; Ohnishi K
Nihon Rinsho; 2002 Jan; 60 Suppl 1():371-5. PubMed ID: 11838141
[No Abstract] [Full Text] [Related]
17. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305
[TBL] [Abstract][Full Text] [Related]
18. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
[TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
[TBL] [Abstract][Full Text] [Related]
20. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
